Telehealth vs Web-Based CBT for Insomnia
(CLEAR Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests different methods to help people with insomnia, particularly those with multiple sclerosis (MS). It compares one-on-one telehealth cognitive behavioral therapy (CBT) sessions, an online CBT program, and regular treatment (treatment as usual, TAU) to determine which best improves sleep, reduces fatigue, and enhances quality of life. Researchers will evaluate participants after 6 weeks and again 6 months later. This trial suits individuals with MS who struggle to fall or stay asleep at least three nights a week and have internet access. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group, allowing participants to contribute to important findings.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you are taking benzodiazepines, non-benzodiazepines, or melatonin supplements for insomnia, you must have been on a stable dose for at least 3 months.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that telehealth cognitive behavioral therapy for insomnia (tCBT-I) is safe. One study found that 85% of interested participants qualified, and 98% completed the program, suggesting most can undergo treatment without major issues.
Similarly, web-based CBT-I (wCBT-I) is a safe and effective method for improving sleep. A review of several studies confirmed that internet-based CBT-I significantly improved sleep issues without notable side effects. Another study found it effective even for individuals with other health conditions, such as cancer survivors, again without major safety concerns.
Both treatments are types of behavioral therapy, focusing on changing habits and thoughts rather than using medication. This often results in fewer side effects compared to drug treatments. Overall, research supports that both telehealth and web-based CBT-I are safe options for improving sleep.12345Why are researchers excited about this trial?
Researchers are excited about the trial comparing telehealth and web-based cognitive behavioral therapy for insomnia because these approaches offer unique flexibility and accessibility that standard treatments, like in-person therapy or medication, often lack. Telehealth CBT-I provides personalized, one-on-one sessions through video conferencing, making it easier for individuals with busy schedules or mobility issues to receive care from home. Meanwhile, the web-based CBT-I program delivers structured, interactive lessons that patients can work through at their own pace, accommodating different learning styles and schedules. These innovative delivery methods could make effective insomnia treatment more widely available and convenient for people who struggle to access traditional in-person therapy.
What evidence suggests that this trial's treatments could be effective for insomnia?
This trial will compare Telehealth cognitive behavioral therapy for insomnia (tCBT-I) with Web-based cognitive behavioral therapy for insomnia (wCBT-I) and Treatment as usual (TAU). Research has shown that telehealth cognitive behavioral therapy for insomnia (tCBT-I) can greatly improve sleep quality and reduce insomnia symptoms. One study found that it improved insomnia severity, sleep efficiency, and overall sleep quality. Another study showed that telehealth and in-person CBT-I were equally effective for treating insomnia. Web-based CBT-I (wCBT-I) is also effective, with research confirming it improves sleep both in subjective and measurable ways. Online programs can lessen insomnia severity and reduce pre-sleep alertness. Both telehealth and web-based CBT-I have shown promising results in enhancing sleep quality.24678
Are You a Good Fit for This Trial?
This trial is for adults aged 18-65 with relapsing-remitting or secondary progressive MS, experiencing sleep issues at least three nights a week for the past three months. Participants should have mild-to-moderate disability, be English-speaking, and have internet access. Those with severe disabilities or other sleep disorders are excluded.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either telehealth-delivered CBT-I or web-based CBT-I for 6 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Telehealth cognitive behavioral therapy for insomnia (tCBT-I)
- Treatment as usual (TAU)
- Web-based cognitive behavioral therapy for insomnia (wCBT-I)
Trial Overview
The study compares one-on-one telehealth CBT-I (tCBT-I) and web-based CBT-I (wCBT-I) against usual treatments to see which improves sleep, reduces fatigue, enhances quality of life, and potentially protects the brain in people with MS.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
The Go!ToSleep online program is a 6-week interactive, web-based program that delivers typical CBT-I treatment techniques of stimulus control, sleep restriction, behavioral modifications, relaxation techniques and cognitive restructuring with daily lessons (41 lessons in total)
The treatment as usual comparison group will be encouraged to continue with their usual care recommended by their physician and their usual activities and sleep habits during the period between baseline and 6-month reassessment.
1x/week, 6-week 45-60 min one-one-one manualized program via video conferencing (HIPAA-compliant Zoom) with a trained research assistant that includes time in bed restriction, stimulus control, relaxation strategies, cognitive restructuring, and sleep health promotion education.
Telehealth cognitive behavioral therapy for insomnia (tCBT-I) is already approved in United States, European Union, Canada for the following indications:
- Insomnia
- Sleep Disturbances
- Fatigue
- Insomnia
- Sleep Disorders
- Mood Disorders
- Insomnia
- Sleep Disturbances
- Fatigue
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Kansas Medical Center
Lead Sponsor
Published Research Related to This Trial
Citations
Telehealth-Delivered Cognitive Behavioral Therapy for ...
One recent study reported a significant improvement in insomnia symptoms, sleep quality, fatigue, sleep self-efficacy, and depression symptoms ...
Efficacy of eHealth Versus In-Person Cognitive Behavioral ...
Conclusions: eCBTI and ipCBTI were found to be statistically significantly equivalent for treating insomnia for most examined outcomes, ...
Digital Cognitive Behavioral Therapy vs Medication ...
In this study, clinical evidence suggested that combination therapy was optimal, and dCBT-I was more effective than medication therapy, with long-term benefits ...
Internet-delivered Cognitive Behavioral Therapy for Insomnia
confirmed that eCBT-I significantly improves insomnia severity, sleep efficiency, sleep quality, latency, and total sleep time, achieving ...
Comparative efficacy of onsite, digital, and other settings ...
All examined CBT-I settings except telehealth yielded a significant reduction of the objective total sleep time compared to WL. Medium negative ...
Telehealth group Cognitive-Behavioral Therapy for Insomnia ...
Results: Telehealth group CBT-I was deemed safe. Following the 76% screening rate, 85% of interested individuals met study eligibility and 98% ...
Digital cognitive behavioral therapy for insomnia
The AASM recommends clinicians use cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment for chronic insomnia in adults.
A randomized controlled trial of a digital cognitive ...
Meta-analyses support CBT-I as efficacious and safe, with long-lasting effects in older adults. As a behavioral rather than pharmacological ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.